Pharmaceutical 6,5 Heterobicyclic Ring Derivatives

The invention relates to 6,5 heterobicyclic ring derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use for the treatment of inflammatory conditions driven by STING activation, such as, but not confined to, SLE and geographic atrophy.

Saved in:
Bibliographic Details
Main Authors Townsend, Robert James, Richardson, Anthony John, Smalley, Adam Peter, Lallemand, Benedicte, Hallside, Michal Sarah, Lowe, Martin Alexander, Heer, Jag Paul, Llaveria Cros, Josep, Li, Xianfu
Format Patent
LanguageEnglish
Published 24.12.2020
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The invention relates to 6,5 heterobicyclic ring derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use for the treatment of inflammatory conditions driven by STING activation, such as, but not confined to, SLE and geographic atrophy.
Bibliography:Application Number: US201916969291